Progress on Methods of T Lymphocyte Development

Overview

Journal Zhejiang Da Xue Xue Bao Yi Xue Ban

Specialty General Medicine

Date 2023 May 18

PMID 37202105

Authors

Yun Li

Xin Chen

Affiliations

Soon will be listed here.

Abstract

T lymphocytes (T cells) play an important role in adoptive cellular immunotherapy (ACT). T cells can be stably derived and easily obtained by various methods of T cell development , which have more advantages than traditional methods of T cells isolated from autologous or allogeneic tissues. At present, there are mainly three methods for T cell development : fetal thymus organ culture, recombinant thymus organ culture and two-dimensional culture driven by Notch signal. Fetal thymus organ culture is easy to operate, the isolated thymus can support T cell differentiation and development to maturity , but the intact thymus has problems of limited maintenance time and difficulty in cell harvesting. In recombinant thymic organ culture, various thymic stromal cells are dispersed and recombined to construct a three-dimensional culture environment, which can support T cell maturation and ; however, biomaterials and three-dimensional environment may lead to limited culture maintenance time and cell yield. Two-dimensional culture method uses artificial presentation of Notch signaling pathway ligands to drive T cell differentiation and development; the culture architecture is simple and stable, but it can only support T cell development to the early immature stage. This article reviews the research progress of various culture methods of T cell development , and discusses the existing problems and the future development to facilitate the application of ACT.

References

Nakayama Y, Masuda Y, Ohta H, Tanaka T, Washida M, Nabeshima Y . Fgf21 regulates T-cell development in the neonatal and juvenile thymus. Sci Rep. 2017; 7(1):330. PMC: 5428243. DOI: 10.1038/s41598-017-00349-8. View

Carlyle J, Michie A, Furlonger C, Nakano T, Lenardo M, Paige C . Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med. 1997; 186(2):173-82. PMC: 2198984. DOI: 10.1084/jem.186.2.173. View

Mohtashami M, Zuniga-Pflucker J . Three-dimensional architecture of the thymus is required to maintain delta-like expression necessary for inducing T cell development. J Immunol. 2006; 176(2):730-4. DOI: 10.4049/jimmunol.176.2.730. View

Ye W, Luo C, Li C, Huang J, Liu F . Organoids to study immune functions, immunological diseases and immunotherapy. Cancer Lett. 2020; 477:31-40. DOI: 10.1016/j.canlet.2020.02.027. View

June C, Riddell S, Schumacher T . Adoptive cellular therapy: a race to the finish line. Sci Transl Med. 2015; 7(280):280ps7. DOI: 10.1126/scitranslmed.aaa3643. View

Seet C, He C, Bethune M, Li S, Chick B, Gschweng E . Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat Methods. 2017; 14(5):521-530. PMC: 5426913. DOI: 10.1038/nmeth.4237. View

Ohishi K, Varnum-Finney B, Bernstein I . Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest. 2002; 110(8):1165-74. PMC: 150801. DOI: 10.1172/JCI16167. View

Wang B, Iriguchi S, Waseda M, Ueda N, Ueda T, Xu H . Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Nat Biomed Eng. 2021; 5(5):429-440. DOI: 10.1038/s41551-021-00730-z. View

Orlando G, Soker S, Stratta R . Organ bioengineering and regeneration as the new Holy Grail for organ transplantation. Ann Surg. 2013; 258(2):221-32. DOI: 10.1097/SLA.0b013e31829c79cf. View

10.

Maeda T, Nagano S, Ichise H, Kataoka K, Yamada D, Ogawa S . Regeneration of CD8αβ T Cells from T-cell-Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity. Cancer Res. 2016; 76(23):6839-6850. DOI: 10.1158/0008-5472.CAN-16-1149. View

11.

Ocampo J, de Brito J, Correa-de-Santana E, Borojevic R, Villa-Verde D, Savino W . Laminin-211 controls thymocyte--thymic epithelial cell interactions. Cell Immunol. 2008; 254(1):1-9. DOI: 10.1016/j.cellimm.2008.06.005. View

12.

Hirano K, Suganami A, Tamura Y, Yagita H, Habu S, Kitagawa M . Delta-like 1 and Delta-like 4 differently require their extracellular domains for triggering Notch signaling in mice. Elife. 2020; 9. PMC: 6986876. DOI: 10.7554/eLife.50979. View

13.

Honda T, Ando M, Ando J, Ishii M, Sakiyama Y, Ohara K . Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers. Mol Ther. 2020; 28(11):2394-2405. PMC: 7646217. DOI: 10.1016/j.ymthe.2020.07.004. View

14.

Smirnov S, Petukhov A, Levchuk K, Kulemzin S, Staliarova A, Lepik K . Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials. Front Immunol. 2022; 12:780145. PMC: 8714645. DOI: 10.3389/fimmu.2021.780145. View

15.

Bosticardo M, Pala F, Calzoni E, Delmonte O, Dobbs K, Gardner C . Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia. Blood Adv. 2020; 4(12):2611-2616. PMC: 7322962. DOI: 10.1182/bloodadvances.2020001730. View

16.

Ghosh A, Smith M, James S, Davila M, Velardi E, Argyropoulos K . Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity. Nat Med. 2017; 23(2):242-249. PMC: 5528161. DOI: 10.1038/nm.4258. View

17.

Bortolomai I, Sandri M, Draghici E, Fontana E, Campodoni E, Marcovecchio G . Gene Modification and Three-Dimensional Scaffolds as Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches. Stem Cells Transl Med. 2019; 8(10):1107-1122. PMC: 6766605. DOI: 10.1002/sctm.18-0218. View

18.

Han J, Zuniga-Pflucker J . High-Oxygen Submersion Fetal Thymus Organ Cultures Enable FOXN1-Dependent and -Independent Support of T Lymphopoiesis. Front Immunol. 2021; 12:652665. PMC: 8043069. DOI: 10.3389/fimmu.2021.652665. View

19.

Mizoguchi T, Handa H, Omaru S, Itoh M . Artificial Notch Signaling Activation Method Using Immobilized Ligand Beads. Methods Mol Biol. 2022; 2472:57-66. DOI: 10.1007/978-1-0716-2201-8_6. View

20.

Zakrzewski J, Suh D, Markley J, Smith O, King C, Goldberg G . Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol. 2008; 26(4):453-61. PMC: 2731996. DOI: 10.1038/nbt1395. View